Literature DB >> 3522912

Screening, early neonatal diagnosis and prenatal diagnosis.

J A Kuzemko.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3522912      PMCID: PMC1290117     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  29 in total

Review 1.  Cystic fibrosis.

Authors:  R E Wood; T F Boat; C F Doershuk
Journal:  Am Rev Respir Dis       Date:  1976-06

2.  Studies on ciliary dyskinesia factor in cystic fibrosis. 3. Skin fibroblasts and cultured amniotic fluid cells.

Authors:  N G Beratis; J H Conover; E J Conod; R J Bonforte; K Hirschhorn
Journal:  Pediatr Res       Date:  1973-12       Impact factor: 3.756

3.  Abnormality of the epididymis and vas deferens in cystic fibrosis.

Authors:  B H Landing; T R Wells; C I Wang
Journal:  Arch Pathol       Date:  1969-12

4.  Prenatal diagnosis of cystic fibrosis.

Authors:  G Mastella; S Perobelli; G Borgo
Journal:  Lancet       Date:  1985-09-07       Impact factor: 79.321

5.  Methylumbelliferyl-guanidinobenzoate reactive proteases in amniotic fluid: possible marker for cystic fibrosis.

Authors:  M M Walsh; H L Nadler
Journal:  Lancet       Date:  1979-03-17       Impact factor: 79.321

6.  Dried-blood spot screening for cystic fibrosis in the newborn.

Authors:  J R Crossley; R B Elliott; P A Smith
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

7.  Is cystic fibrosis protein a diagnostic marker for individuals who harbor the defective gene?

Authors:  G B Wilson; H H Fudenberg
Journal:  Pediatr Res       Date:  1978-07       Impact factor: 3.756

Review 8.  Research in cystic fibrosis (third of three parts).

Authors:  P A di Sant'Agnese; P B Davis
Journal:  N Engl J Med       Date:  1976-09-09       Impact factor: 91.245

9.  Diagnosis of heterozygosity for cystic fibrosis by discriminatory analysis of sweat chloride distribution.

Authors:  A Sproul; N Huang
Journal:  J Pediatr       Date:  1966-11       Impact factor: 4.406

10.  Enhanced dexamethasone resistance in cystic fibrosis cells: potential use for heterozygote detection and prenatal diagnosis.

Authors:  J L Breslow; J Epstein; J H Fontaine; G B Forbes
Journal:  Science       Date:  1978-07-14       Impact factor: 47.728

View more
  1 in total

1.  Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing.

Authors:  J Massie; L Curnow; N Tzanakos; I Francis; C F Robertson
Journal:  Arch Dis Child       Date:  2005-10-21       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.